SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-24-001131
Filing Date
2024-01-08
Accepted
2024-01-08 16:32:23
Documents
1
Period of Report
2024-01-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6086
  Complete submission text file 0001209191-24-001131.txt   7741
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 646-844-1164
ORAMED PHARMACEUTICALS INC. (Issuer) CIK: 0001176309 (see all company filings)

IRS No.: 980376008 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address
Shapiro Benjamin (Reporting) CIK: 0001974846 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35813 | Film No.: 24520540